ProfileGDS4718 / 1554960_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 7% 11% 10% 11% 6% 1% 8% 7% 6% 5% 4% 10% 10% 5% 20% 5% 9% 4% 16% 4% 7% 6% 10% 7% 5% 2% 9% 7% 9% 9% 70% 3% 5% 15% 7% 9% 6% 8% 6% 8% 7% 8% 7% 6% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.685947
GSM549102patient 115, normal, homogenized [OPG study]3.8189711
GSM549104patient 119, normal, homogenized [OPG study]3.7487910
GSM549108patient 138, normal, homogenized [OPG study]3.8285111
GSM549119patient 077, normal, homogenized [OPG study]3.612766
GSM549133patient 032, cancer, homogenized [OPG study]3.277121
GSM549139patient 042, cancer, homogenized [OPG study]3.68378
GSM549099patient 107, normal, homogenized [OPG study]3.653867
GSM549109patient 139, normal, homogenized [OPG study]3.668386
GSM549110patient 046, normal, homogenized [OPG study]3.599125
GSM549114patient 063, normal, homogenized [OPG study]3.507134
GSM549122patient 082, normal, homogenized [OPG study]3.8033210
GSM549134patient 033, cancer, homogenized [OPG study]3.760910
GSM549136patient 036, cancer, homogenized [OPG study]3.549735
GSM549140patient 044, cancer, homogenized [OPG study]4.101320
GSM549111patient 047, normal, homogenized [OPG study]3.56645
GSM549113patient 057, normal, homogenized [OPG study]3.727719
GSM549132patient 031, cancer, homogenized [OPG study]3.545864
GSM549137patient 038, cancer, homogenized [OPG study]3.9806316
GSM549142patient 047, cancer, homogenized [OPG study]3.583484
GSM549100patient 110, normal, homogenized [OPG study]3.684817
GSM549107patient 135, normal, homogenized [OPG study]3.595016
GSM549115patient 068, normal, homogenized [OPG study]3.7519710
GSM549116patient 072, normal, homogenized [OPG study]3.658977
GSM549120patient 078, normal, homogenized [OPG study]3.576015
GSM549131patient 030, cancer, homogenized [OPG study]3.406582
GSM549118patient 074, normal, homogenized [OPG study]3.737769
GSM549129patient 027, cancer, homogenized [OPG study]3.675347
GSM549123patient 088, normal, homogenized [OPG study]3.764979
GSM549124patient 006, cancer, homogenized [OPG study]3.779119
GSM549126patient 015, cancer, homogenized [OPG study]6.8473670
GSM549128patient 025, cancer, homogenized [OPG study]3.479133
GSM549103patient 117, normal, homogenized [OPG study]3.585215
GSM549117patient 073, normal, homogenized [OPG study]3.9530415
GSM549138patient 041, cancer, homogenized [OPG study]3.651087
GSM549141patient 045, cancer, homogenized [OPG study]3.67629
GSM549130patient 028, cancer, homogenized [OPG study]3.6496
GSM549101patient 111, normal, homogenized [OPG study]3.684738
GSM549105patient 128, normal, homogenized [OPG study]3.63316
GSM549106patient 134, normal, homogenized [OPG study]3.662848
GSM549112patient 048, normal, homogenized [OPG study]3.676857
GSM549125patient 011, cancer, homogenized [OPG study]3.72278
GSM549127patient 024, cancer, homogenized [OPG study]3.648577
GSM549135patient 035, cancer, homogenized [OPG study]3.604086